Cruzeiro do Sul Educacional (CSED3) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
28 Aug, 2026Executive summary
Net income for 3Q25 reached R$113 million, up 82% year-over-year, and R$262 million for 9M25, a 70% increase over 9M24, driven by 11% revenue growth and a 9% expansion in the student base.
Adjusted net earnings rose 78.3% in 3Q25 year-over-year and 55.3% for the nine-month period.
Free cash flow to equity reached R$428 million in 9M25, up 66% year-over-year, with 3Q25 at R$221 million, up 35% year-over-year.
Digital and health segments led operational growth, with digital student base up 13% and health courses now representing 71% of on-campus revenue.
Celebrated 60th anniversary in September 2025, highlighting decades of sustainable management and stakeholder value creation.
Financial highlights
Net revenue for 3Q25 was R$694 million (+11.1% YoY); 9M25 revenue was R$2.1 billion (+9.5% YoY).
Adjusted EBITDA for 3Q25 was R$278 million (+29% YoY, margin 40.1%); 9M25 was R$731 million (+21% YoY, margin 35.0%).
Adjusted net income for 3Q25 was R$113 million (+78.3% YoY); 9M25 was R$263 million (+55.3% YoY).
Gross margin for 3Q25 improved to 53.8% (+3.9 p.p. YoY), driven by efficiency and growth in medical and digital courses.
Free cash flow to equity conversion reached 94% of EBITDA in 3Q25 and 77% for 9M25.
Outlook and guidance
Management expects continued growth in digital and hybrid segments, supported by regulatory changes and operational efficiency.
Focus remains on cash generation, operational excellence, and margin expansion.
No specific guidance provided for gross margin or future mix due to regulatory and market uncertainties.
Updated PDA curve will cause seasonality in quarterly results throughout 2025.
Ongoing improvements in credit and collection processes expected to support future margin expansion.
Latest events from Cruzeiro do Sul Educacional
- Revenue and net income surged, driven by student growth, digital gains, and FAPI acquisition.CSED3
Q2 2024 - Record free cash flow and net earnings in 3Q24, with strong growth in students and margins.CSED3
Q3 2024 - Record earnings, robust cash flow, and 12% student growth drove strong 2024 results.CSED3
Q4 2024 - Record earnings, margin expansion, and robust cash flow driven by student and health segment growth.CSED3
Q1 2025 - Net revenue and earnings surged, student base grew 13.9%, and leverage improved to 1.1x.CSED3
Q2 2025 - Record net profit, margin expansion, and robust cash flow highlight strong 2025 performance.CSED3
Q4 2025 - Revenue up 4.5% year-over-year, but net profit down 28.1% amid higher costs and provisions.CSED3
Q1 2026 - Net income rose 61% and adjusted EBITDA margin reached 29.9% on strong healthcare and hybrid growth.CSED3
Q2 2026